Pfizer stock recovers after Covid decline but some employees struggle

Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier, the pharmaceutical giant's stock had closed...

Read more...

Walgreens (WBA) earnings Q3 2024

In an aerial view, a customer enters a Walgreens store on January 04, 2024 in San Pablo, California. Justin Sullivan | Getty ImagesWalgreens on Thursday reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a "challenging" environment for pharmacies and U.S. consumers.The...

Read more...

Biden to lower some drug costs through inflation penalties

US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty ImagesThe Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of...

Read more...

Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility

Novo Nordisk's new manufacturing facility in Clayton, North Carolina.Courtesy: Novo NordiskNovo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other...

Read more...

Eli Lilly expects FDA decision on Zepbound for sleep apnea as early as end of year

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year.If cleared by the Food and Drug Administration, the company plans to...

Read more...

FDA approves Merck pneumococcal disease vaccine designed for adults

Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said.Merck's shot, called Capvaxive, specifically protects...

Read more...

Moderna combination Covid, flu vaccine shows positive late-stage data

Empty bottles of Moderna's Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release positive phase three...

Read more...

FDA approves GSK RSV vaccine for adults 50 to 59

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The...

Read more...